Software - Infrastructure
Compare Stocks
4 / 10Stock Comparison
DOX vs CNXC vs TTEC vs EPAM
Revenue, margins, valuation, and 5-year total return — side by side.
Information Technology Services
Information Technology Services
Information Technology Services
DOX vs CNXC vs TTEC vs EPAM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Software - Infrastructure | Information Technology Services | Information Technology Services | Information Technology Services |
| Market Cap | $7.06B | $1.79B | $149M | $5.51B |
| Revenue (TTM) | $4.58B | $9.83B | $2.10B | $5.56B |
| Net Income (TTM) | $572M | $-1.28B | $-201M | $387M |
| Gross Margin | 37.6% | 33.3% | 15.5% | 28.5% |
| Operating Margin | 17.7% | 6.2% | 4.3% | 9.9% |
| Forward P/E | 8.7x | 2.2x | 2.5x | 8.2x |
| Total Debt | $826M | $4.64B | $1.00B | $144M |
| Cash & Equiv. | $325M | $327M | $83M | $1.30B |
DOX vs CNXC vs TTEC vs EPAM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 20 | May 26 | Return |
|---|---|---|---|
| Amdocs Limited (DOX) | 100 | 99.0 | -1.0% |
| Concentrix Corporat… (CNXC) | 100 | 31.8 | -68.2% |
| TTEC Holdings, Inc. (TTEC) | 100 | 4.5 | -95.5% |
| EPAM Systems, Inc. (EPAM) | 100 | 32.4 | -67.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DOX vs CNXC vs TTEC vs EPAM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DOX carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 12 yrs, beta 0.58, yield 3.1%
- 12.5% margin vs CNXC's -13.0%
- Beta 0.58 vs TTEC's 1.84, lower leverage
- 3.1% yield, 12-year raise streak, vs CNXC's 5.6%, (2 stocks pay no dividend)
CNXC is the #2 pick in this set and the best alternative if defensive is your priority.
- Beta 1.38, yield 5.6%, current ratio 1.40x
- Lower P/E (2.2x vs 8.7x)
TTEC is the clearest fit if your priority is momentum.
- -21.9% vs CNXC's -46.7%
EPAM is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 15.4%, EPS growth -14.3%, 3Y rev CAGR 4.2%
- 48.8% 10Y total return vs DOX's 36.5%
- Lower volatility, beta 1.21, Low D/E 3.9%, current ratio 2.59x
- PEG 0.70 vs DOX's 1.37
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.4% revenue growth vs DOX's -9.4% | |
| Value | Lower P/E (2.2x vs 8.7x) | |
| Quality / Margins | 12.5% margin vs CNXC's -13.0% | |
| Stability / Safety | Beta 0.58 vs TTEC's 1.84, lower leverage | |
| Dividends | 3.1% yield, 12-year raise streak, vs CNXC's 5.6%, (2 stocks pay no dividend) | |
| Momentum (1Y) | -21.9% vs CNXC's -46.7% | |
| Efficiency (ROA) | 9.0% ROA vs TTEC's -14.2%, ROIC 15.6% vs 6.2% |
DOX vs CNXC vs TTEC vs EPAM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DOX vs CNXC vs TTEC vs EPAM — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
DOX leads in 4 of 6 categories
CNXC leads 1 • TTEC leads 0 • EPAM leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
DOX leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CNXC is the larger business by revenue, generating $9.8B annually — 4.7x TTEC's $2.1B. DOX is the more profitable business, keeping 12.5% of every revenue dollar as net income compared to CNXC's -13.0%. On growth, EPAM holds the edge at +7.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $4.6B | $9.8B | $2.1B | $5.6B |
| EBITDAEarnings before interest/tax | $1.0B | $773M | $178M | $684M |
| Net IncomeAfter-tax profit | $572M | -$1.3B | -$201M | $387M |
| Free Cash FlowCash after capex | $755M | $572M | $34M | $544M |
| Gross MarginGross profit ÷ Revenue | +37.6% | +33.3% | +15.5% | +28.5% |
| Operating MarginEBIT ÷ Revenue | +17.7% | +6.2% | +4.3% | +9.9% |
| Net MarginNet income ÷ Revenue | +12.5% | -13.0% | -9.6% | +7.0% |
| FCF MarginFCF ÷ Revenue | +16.5% | +5.8% | +1.6% | +9.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.1% | +4.3% | -7.1% | +7.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +9.0% | -14.9% | -6.6% | +18.8% |
Valuation Metrics
CNXC leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 12.9x trailing earnings, DOX trades at a 17% valuation discount to EPAM's 15.5x P/E. Adjusting for growth (PEG ratio), DOX offers better value at 2.03x vs EPAM's 4.18x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $7.1B | $1.8B | $149M | $5.5B |
| Enterprise ValueMkt cap + debt − cash | $7.6B | $6.1B | $1.1B | $4.4B |
| Trailing P/EPrice ÷ TTM EPS | 12.90x | -1.25x | -0.77x | 15.53x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.74x | 2.17x | 2.52x | 8.17x |
| PEG RatioP/E ÷ EPS growth rate | 2.03x | — | — | 4.18x |
| EV / EBITDAEnterprise value multiple | 7.43x | 4.84x | 5.76x | 6.74x |
| Price / SalesMarket cap ÷ Revenue | 1.56x | 0.18x | 0.07x | 1.01x |
| Price / BookPrice ÷ Book value/share | 2.10x | 0.58x | 1.31x | 1.60x |
| Price / FCFMarket cap ÷ FCF | 10.95x | 3.13x | 1.82x | 8.99x |
Profitability & Efficiency
DOX leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
DOX delivers a 16.5% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-100 for TTEC. EPAM carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to TTEC's 8.86x. On the Piotroski fundamental quality scale (0–9), DOX scores 6/9 vs TTEC's 5/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +16.5% | -33.2% | -99.6% | +10.7% |
| ROA (TTM)Return on assets | +9.0% | -10.8% | -14.2% | +8.1% |
| ROICReturn on invested capital | +15.6% | +5.6% | +6.2% | +15.5% |
| ROCEReturn on capital employed | +16.8% | +6.6% | +7.5% | +13.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.24x | 1.69x | 8.86x | 0.04x |
| Net DebtTotal debt minus cash | $501M | $4.3B | $917M | -$1.2B |
| Cash & Equiv.Liquid assets | $325M | $327M | $83M | $1.3B |
| Total DebtShort + long-term debt | $826M | $4.6B | $1.0B | $144M |
| Interest CoverageEBIT ÷ Interest expense | 23.45x | -3.07x | -4.22x | — |
Total Returns (Dividends Reinvested)
DOX leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DOX five years ago would be worth $9,650 today (with dividends reinvested), compared to $556 for TTEC. Over the past 12 months, TTEC leads with a -21.9% total return vs CNXC's -46.7%. The 3-year compound annual growth rate (CAGR) favors DOX at -7.7% vs TTEC's -51.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -18.0% | -36.5% | -14.3% | -47.9% |
| 1-Year ReturnPast 12 months | -24.7% | -46.7% | -21.9% | -34.4% |
| 3-Year ReturnCumulative with dividends | -21.3% | -65.7% | -88.9% | -55.0% |
| 5-Year ReturnCumulative with dividends | -3.5% | -80.3% | -94.4% | -77.3% |
| 10-Year ReturnCumulative with dividends | +36.5% | -61.0% | -61.8% | +48.8% |
| CAGR (3Y)Annualised 3-year return | -7.7% | -30.0% | -51.9% | -23.4% |
Risk & Volatility
DOX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
DOX is the less volatile stock with a 0.58 beta — it tends to amplify market swings less than TTEC's 1.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DOX currently trades 68.3% from its 52-week high vs CNXC's 41.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.58x | 1.38x | 1.84x | 1.21x |
| 52-Week HighHighest price in past year | $95.41 | $62.14 | $5.60 | $222.53 |
| 52-Week LowLowest price in past year | $62.75 | $22.85 | $1.98 | $99.67 |
| % of 52W HighCurrent price vs 52-week peak | +68.3% | +41.0% | +54.6% | +46.9% |
| RSI (14)Momentum oscillator 0–100 | 41.9 | 36.1 | 52.9 | 22.5 |
| Avg Volume (50D)Average daily shares traded | 980K | 1.6M | 662K | 1.3M |
Analyst Outlook
Evenly matched — DOX and CNXC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DOX as "Buy", CNXC as "Buy", TTEC as "Hold", EPAM as "Buy". Consensus price targets imply 1016.7% upside for TTEC (target: $34) vs 38.2% for DOX (target: $90). For income investors, CNXC offers the higher dividend yield at 5.59% vs DOX's 3.08%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $90.00 | $52.00 | $34.17 | $197.00 |
| # AnalystsCovering analysts | 11 | 9 | 14 | 37 |
| Dividend YieldAnnual dividend ÷ price | +3.1% | +5.6% | — | — |
| Dividend StreakConsecutive years of raises | 12 | 5 | 0 | — |
| Dividend / ShareAnnual DPS | $2.01 | $1.42 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +7.8% | +10.5% | 0.0% | 0.0% |
DOX leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CNXC leads in 1 (Valuation Metrics). 1 tied.
DOX vs CNXC vs TTEC vs EPAM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DOX or CNXC or TTEC or EPAM a better buy right now?
For growth investors, EPAM Systems, Inc.
(EPAM) is the stronger pick with 15. 4% revenue growth year-over-year, versus -9. 4% for Amdocs Limited (DOX). Amdocs Limited (DOX) offers the better valuation at 12. 9x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate Amdocs Limited (DOX) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DOX or CNXC or TTEC or EPAM?
On trailing P/E, Amdocs Limited (DOX) is the cheapest at 12.
9x versus EPAM Systems, Inc. at 15. 5x. On forward P/E, Concentrix Corporation is actually cheaper at 2. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: EPAM Systems, Inc. wins at 0. 70x versus Amdocs Limited's 1. 37x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — DOX or CNXC or TTEC or EPAM?
Over the past 5 years, Amdocs Limited (DOX) delivered a total return of -3.
5%, compared to -94. 4% for TTEC Holdings, Inc. (TTEC). Over 10 years, the gap is even starker: EPAM returned +48. 8% versus TTEC's -61. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DOX or CNXC or TTEC or EPAM?
By beta (market sensitivity over 5 years), Amdocs Limited (DOX) is the lower-risk stock at 0.
58β versus TTEC Holdings, Inc. 's 1. 84β — meaning TTEC is approximately 220% more volatile than DOX relative to the S&P 500. On balance sheet safety, EPAM Systems, Inc. (EPAM) carries a lower debt/equity ratio of 4% versus 9% for TTEC Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DOX or CNXC or TTEC or EPAM?
By revenue growth (latest reported year), EPAM Systems, Inc.
(EPAM) is pulling ahead at 15. 4% versus -9. 4% for Amdocs Limited (DOX). On earnings-per-share growth, the picture is similar: TTEC Holdings, Inc. grew EPS 40. 8% year-over-year, compared to -648. 8% for Concentrix Corporation. Over a 3-year CAGR, CNXC leads at 15. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DOX or CNXC or TTEC or EPAM?
Amdocs Limited (DOX) is the more profitable company, earning 12.
5% net margin versus -13. 0% for Concentrix Corporation — meaning it keeps 12. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DOX leads at 18. 2% versus 4. 5% for TTEC. At the gross margin level — before operating expenses — DOX leads at 36. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DOX or CNXC or TTEC or EPAM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, EPAM Systems, Inc. (EPAM) is the more undervalued stock at a PEG of 0. 70x versus Amdocs Limited's 1. 37x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Concentrix Corporation (CNXC) trades at 2. 2x forward P/E versus 8. 7x for Amdocs Limited — 6. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TTEC: 1016. 7% to $34. 17.
08Which pays a better dividend — DOX or CNXC or TTEC or EPAM?
In this comparison, CNXC (5.
6% yield), DOX (3. 1% yield) pay a dividend. TTEC, EPAM do not pay a meaningful dividend and should not be held primarily for income.
09Is DOX or CNXC or TTEC or EPAM better for a retirement portfolio?
For long-horizon retirement investors, Amdocs Limited (DOX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
58), 3. 1% yield). TTEC Holdings, Inc. (TTEC) carries a higher beta of 1. 84 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DOX: +36. 5%, TTEC: -61. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DOX and CNXC and TTEC and EPAM?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: DOX is a small-cap deep-value stock; CNXC is a small-cap income-oriented stock; TTEC is a small-cap quality compounder stock; EPAM is a small-cap high-growth stock. DOX, CNXC pay a dividend while TTEC, EPAM do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.